SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003447
Filing Date
2021-11-08
Accepted
2021-11-08 16:02:50
Documents
87
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eftr-20210930.htm   iXBRL 10-Q 3069989
2 EX-10.1 eftr-ex10_1.htm EX-10.1 37309
3 EX-10.2 eftr-ex10_2.htm EX-10.2 175901
4 EX-31.1 eftr-ex31_1.htm EX-31.1 19401
5 EX-31.2 eftr-ex31_2.htm EX-31.2 19360
6 EX-32.1 eftr-ex32_1.htm EX-32.1 10834
7 EX-32.2 eftr-ex32_2.htm EX-32.2 10799
  Complete submission text file 0000950170-21-003447.txt   12477676

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eftr-20210930_lab.xml EX-101.LAB 575919
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eftr-20210930.xsd EX-101.SCH 81770
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eftr-20210930_pre.xml EX-101.PRE 475499
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eftr-20210930_def.xml EX-101.DEF 344173
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eftr-20210930_cal.xml EX-101.CAL 39829
13 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20210930_htm.xml XML 2591710
Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39866 | Film No.: 211387841
SIC: 2834 Pharmaceutical Preparations